ADAC names interim CFO

Article

As it struggles to cope with accounting irregularities, ADAC Laboratories of Milpitas, CA, announced a replacement for its chief financial officer, Andre Simone. Effective this month, Robert Bunje will serve as ADAC’s interim CFO while the

As it struggles to cope with accounting irregularities, ADAC Laboratories of Milpitas, CA, announced a replacement for its chief financial officer, Andre Simone. Effective this month, Robert Bunje will serve as ADAC’s interim CFO while the company searches for a permanent replacement. Bunje brings to the position 25 years of experience as a partner at Deloitte & Touche, where he served before his retirement in 1994 as managing director for the company’s international merger and acquisition services division. Simone will continue to serve as a consultant to ADAC, the company said.

The news of Simone’s departure from the CFO post comes in the midst of ADAC’s struggle with accounting problems: Late last year, ADAC announced that it would have to restate revenues for the past three years (SCAN 5/26/99). On May 19, just days before the company announced Bunje’s appointment to the interim CFO post, ADAC reported that it would delay the release of its second quarter (end-April) financial results as it determines whether to establish additional reserves.

In other ADAC news, former chief executive David Lowe severed his last ties with the company when he relinquished his seat on the vendor’s board late last month. Lowe helped transform ADAC from a struggling company into the market-share leader in nuclear medicine. He resigned his board seat to devote more time to the private investment firm he co-founded.

© 1999 Miller Freeman, Inc.All rights reserved.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.